留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

卵巢非侵袭性低级别浆液性癌保留生育功能手术五例及文献复习

李雷 冯凤芝 范融 娄文佳 李源 仝佳丽 常晓燕 潘凌亚

李雷, 冯凤芝, 范融, 娄文佳, 李源, 仝佳丽, 常晓燕, 潘凌亚. 卵巢非侵袭性低级别浆液性癌保留生育功能手术五例及文献复习[J]. 协和医学杂志, 2016, 7(4): 285-289. doi: 10.3969/j.issn.1674-9081.2016.04.009
引用本文: 李雷, 冯凤芝, 范融, 娄文佳, 李源, 仝佳丽, 常晓燕, 潘凌亚. 卵巢非侵袭性低级别浆液性癌保留生育功能手术五例及文献复习[J]. 协和医学杂志, 2016, 7(4): 285-289. doi: 10.3969/j.issn.1674-9081.2016.04.009
Lei LI, Feng-zhi FENG, Rong FAN, Wen-jia LOU, Yuan LI, Jia-li TONG, Xiao-yan CHANG, Ling-ya PAN. Fertility-sparing Surgery for Ovarian Non-invasive Low-grade Serous Carcinoma and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(4): 285-289. doi: 10.3969/j.issn.1674-9081.2016.04.009
Citation: Lei LI, Feng-zhi FENG, Rong FAN, Wen-jia LOU, Yuan LI, Jia-li TONG, Xiao-yan CHANG, Ling-ya PAN. Fertility-sparing Surgery for Ovarian Non-invasive Low-grade Serous Carcinoma and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(4): 285-289. doi: 10.3969/j.issn.1674-9081.2016.04.009

卵巢非侵袭性低级别浆液性癌保留生育功能手术五例及文献复习

doi: 10.3969/j.issn.1674-9081.2016.04.009
详细信息
    通讯作者:

    冯凤芝 电话:010-69156204, E-mail:fengfz1969@sina.com

  • 中图分类号: R713.6

Fertility-sparing Surgery for Ovarian Non-invasive Low-grade Serous Carcinoma and Literature Review

More Information
  • 摘要:   目的  分析卵巢非侵袭性低级别浆液性癌(low-grade serous carcinoma, LGSC)患者保留生育功能手术的特点。  方法  回顾性收集2015年1月至2015年6月北京协和医院病理诊断为卵巢非侵袭性LGSC且进行保留生育功能手术的患者, 对其临床病理特点、手术过程和随访情况进行总结。  结果  共有5例非侵袭性LGSC且保留生育功能患者, 中位年龄29岁(24~34岁); 1例行开腹手术, 4例行腹腔镜手术; 4例手术行卵巢囊肿剔除, 1例患者因为卵巢急性扭转坏死行受累附件切除。1例国际妇产科联盟(International Federation of Gynecology and Obstetrics, FIGO)分期为IB期, 4例为IA期。所有患者术后均未接受进一步治疗。中位随访7个月(6~12个月), 所有患者均未复发, 1例患者自然受孕且母胎情况良好。  结论  对于非侵袭性LGSC患者, 能否保留生育功能、保留生育功能手术术后的生育情况、复发率及随诊方案, 仍是目前临床处理的棘手问题。本研究为年轻的非侵袭性LGSC患者提供了保留卵巢的选择, 但患者的长期预后(包括生育和生存)尚有待进一步随访。
  • 图  1  病例1的术前CT示附件来源病灶

    A.右附件区病灶推挤子宫、膀胱;B.病灶为混合性包块,有分隔

    图  2  病例1的术中解剖示意图

    A.右卵巢肿瘤;B.左卵巢肿瘤

    图  3  微乳头亚型的浆液性交界性肿瘤/卵巢非侵袭性低级别浆液性癌病理(苏木精-伊红染色,×10)

  • [1] Kurman RJ, Carcangiu ML, Herrington CS, eds. World Health Organization Classification of Tumours[M]. 4 ed. Lyon:International Agency for Research on Cancer, 2014.
    [2] Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases[J]. Am J Surg Pathol, 1996, 20:1331-1345. doi:  10.1097/00000478-199611000-00004
    [3] Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma[J]. Am J Surg Pathol, 2010, 34:627-635. doi:  10.1097/PAS.0b013e3181da7687
    [4] Barcena C, Oliva E. WT1 expression in the female genital tract[J]. Adv Anat Pathol, 2011, 18:454-465. doi:  10.1097/PAP.0b013e318234aaed
    [5] Escobar J, Klimowicz AC, Dean M, et al. Quantification of ER/PR expression in ovarian low-grade serous carcinoma[J]. Gynecol Oncol, 2013, 128:371-376. doi:  10.1016/j.ygyno.2012.10.013
    [6] Singer G, Oldt R 3rd, Cohen Y, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma[J]. J Natl Cancer Inst, 2003, 95:484-486. doi:  10.1093/jnci/95.6.484
    [7] Jones S, Wang TL, Kurman RJ, et al. Low-grade serous carcinomas of the ovary contain very few point mutations[J]. J Pathol, 2012, 226:413-420. doi:  10.1002/path.3967
    [8] Vang R, Shih Ie M, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma:pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems[J]. Adv Anat Pathol, 2009, 16:267-282. doi:  10.1097/PAP.0b013e3181b4fffa
    [9] Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer:a proposed unifying theory[J]. Am J Surg Pathol, 2010, 34:433-443. doi:  10.1097/PAS.0b013e3181cf3d79
    [10] Kuo KT, Guan B, Feng Y, et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas[J]. Cancer Res, 2009, 69:4036-4042. doi:  10.1158/0008-5472.CAN-08-3913
    [11] Hannibal CG, Vang R, Junge J, et al. A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002:Centralized pathology review and overall survival compared with the general population[J]. Gynecol Oncol, 2014, 134:267-273. doi:  10.1016/j.ygyno.2014.06.002
    [12] Roma A, Malpica A, Deavers M, et al. Ovarian serous borderline tumors with a predominant micropapillary pattern are aggresslve neoplasms with an increased risk of low grade serous carcinoma[J]. Modern Pathol, 2008, 21:221A.
    [13] National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology (NCCN Guideline), Ovarian Cancer, Version 2.2015[EB/OL].[2015-07-10]. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  • 加载中
图(3)
计量
  • 文章访问数:  132
  • HTML全文浏览量:  37
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-07-15
  • 刊出日期:  2016-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!